Lv11
30 积分 2026-07-10 加入
Glecirasib plus sitneprotafib in patients with KRASG12C-mutated non-small-cell lung cancer in China: an open-label, multicentre, single-arm, phase 1/2a trial
2小时前
已完结
First-line serplulimab plus chemotherapy with or without HLX04 versus chemotherapy in locally advanced or metastatic non-squamous non-small-cell lung cancer (ASTRUM-002): a randomised, double-blind, multicentre phase 3 trial
2小时前
已完结
Cost Evaluation of a Multimodal Prehabilitation Program for High-risk Lung Cancer Surgery
2小时前
求助中
皖公网安备34019202002308
